Overview Our Strategy How we are delivering on our strategy A strategy for long-term growth Deeper customer engagement Our vision is to become the leading global provider of speciality food ingredients and We believe that getting closer to solutions.
Our strategy is to deliver this our customers, developing a better understanding of their needs and visionthrough: changing the way we interact with them is a key part of delivering sustainable  long-term growth.
Food Ingredients business unit through: Our new global Commercial and Food Innovation Centre in Chicago, which we deeper customer understanding opened to customers in June 2012, helps us transform the way we work with our continuous innovation customers.
It has: Full sensory capabilities stronger positions in high-growth markets Full culinary capabilities  High-tech food processing laboratories sustained cash generation to fuel this growth A pilot plant sample preparation area Global access, communications and capabilities The ability to expand into new applications Speciality Food Ingredients: pg 15 Bulk Ingredients: pg 18 Innovation and Commercial Development: pg 20 Tate & Lyle PLC Annual Report 2013 06 Overview Overview Speciality Food Ingredients Bulk Ingredients Innovation New markets and Sustained cash customer channels generation Creating a world-class innovation Our aim is to build our presence Within Bulk Ingredients our strategy is capability is a key part of our growth significantly in emerging markets to provide stable, long-term cash flow strategy.
The Innovation and Commercial and those parts of the speciality food to help fund growth in Speciality Food Development ICD group provides a fully ingredients market where historically Ingredients.
We aim to achieve this by: integrated approach to developing and we have been under-represented, commercialising innovation to meet our specifically in SMEs and private label.
Reducing earnings volatility by customers needs.
Ideas within our diversifying our income streams into innovation pipeline are derived from Emerging markets new areas three sources: Building dedicated go-to-market Optimising margins by gradually teams in both Asia Pacific and moving a proportion of the corn that In-house innovation part of ICD Latin America we grind away from markets that are in New products or technologies long-term structural decline into higher Strengthening our sales and technical generated by in-house scientists margin speciality food ingredients resources Open innovation part of ICD Ensuring the security of our raw Investing in local infrastructure with the material supply Leverages our global network of opening of new satellite applications research institutions, start-ups and and technical services facilities in Reducing costs and continuing to universities Mexico City, So Paulo and Shanghai improve operational efficiency Provides route-to-market for SMEs and private label technologies or products close Changing the way we access and to commercial launch work with SME and private label Tate & Lyle ventures customers by developing more direct relationships Leverages our global network of research institutions, venture funds, universities and entrepreneurs Invests in early-stage companies and manages them to exit in three to five years Mexico City Applications Technical Services Facilities So Paulo Applications Technical Services Facilities Recent investments in our innovation network.
Tate & Lyle PLC Annual Report 2013 07
